{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:50:55Z","timestamp":1790805055464,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jocn.2013.11.048","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T15:17:49Z","timestamp":1399389469000},"page":"1627-1631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage"],"prefix":"10.1016","volume":"21","author":[{"given":"Ricardo H.","family":"Roda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.11.048_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-009-0196-y","article-title":"Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management","volume":"11","author":"Anheim","year":"2010","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jocn.2013.11.048_b0010","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/brain\/awp211","article-title":"Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients","volume":"132","author":"Anheim","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.11.048_b0015","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.65.7.958","article-title":"Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families","volume":"65","author":"Anheim","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2013.11.048_b0020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1212\/01.WNL.0000145604.57000.36","article-title":"Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype","volume":"63","author":"Criscuolo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.11.048_b0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1212\/01.wnl.0000208402.10512.4a","article-title":"Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study","volume":"66","author":"Criscuolo","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.11.048_b0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.20408","article-title":"Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy","volume":"57","author":"Duquette","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.11.048_b0035","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1212\/01.wnl.0000247661.19601.28","article-title":"Novel mutations in the senataxin DNA\/RNA helicase domain in ataxia with oculomotor apraxia 2","volume":"67","author":"Fogel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.11.048_b0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/brain\/awh080","article-title":"Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients","volume":"127","author":"Le Ber","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.11.048_b0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2008.12.004","article-title":"Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients","volume":"278","author":"Tazir","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2013.11.048_b0050","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.wnl.0000216135.59699.9b","article-title":"Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX","volume":"66","author":"Asaka","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.11.048_b0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00415-004-0427-y","article-title":"Autosomal recessive spinocerebellar ataxia and peripheral neuropathy with raised alpha-fetoprotein","volume":"251","author":"Izatt","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2013.11.048_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410440220","article-title":"Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein","volume":"44","author":"Watanabe","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.11.048_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11910-005-0066-4","article-title":"New autosomal recessive cerebellar ataxias with oculomotor apraxia","volume":"5","author":"Le Ber","year":"2005","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jocn.2013.11.048_b0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0035-3787(06)74997-9","article-title":"Autosomal recessive cerebellar ataxias with oculomotor apraxia","volume":"162","author":"Le Ber","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jocn.2013.11.048_b0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng1001-184","article-title":"Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene","volume":"29","author":"Date","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2013.11.048_b0080","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/brain\/awg283","article-title":"Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies","volume":"126","author":"Le Ber","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.11.048_b0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng1303","article-title":"Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2","volume":"36","author":"Moreira","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2013.11.048_b0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.WNL.0000048562.88536.A4","article-title":"Phenotypic variability of aprataxin gene mutations","volume":"60","author":"Tranchant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.11.048_b0095","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.dnarep.2004.04.010","article-title":"Ataxia-telangiectasia, an evolving phenotype","volume":"3","author":"Chun","year":"2004","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.jocn.2013.11.048_b0100","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jocn.2013.11.048_b0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jmg.30.2.135","article-title":"A family showing no evidence of linkage between the ataxia telangiectasia gene and chromosome 11q22-23","volume":"30","author":"Hernandez","year":"1993","journal-title":"J Med Genet"},{"key":"10.1016\/j.jocn.2013.11.048_b0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)81547-0","article-title":"The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder","volume":"99","author":"Stewart","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jocn.2013.11.048_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nbd.2006.02.007","article-title":"Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease","volume":"23","author":"Chen","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jocn.2013.11.048_b0120","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/nar\/gkh561","article-title":"Multiple protein\/protein and protein\/RNA interactions suggest roles for yeast DNA\/RNA helicase Sen1p in transcription, transcription-coupled DNA repair and RNA processing","volume":"32","author":"Ursic","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jocn.2013.11.048_b0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1083\/jcb.200701042","article-title":"Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage","volume":"177","author":"Suraweera","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jocn.2013.11.048_b0130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","article-title":"DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)","volume":"74","author":"Chen","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jocn.2013.11.048_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mutage\/13.1.1","article-title":"Emerging applications of the single cell gel electrophoresis (Comet) assay. I. Management of invasive transitional cell human bladder carcinoma. II. Fluorescent in situ hybridization Comets for the identification of damaged and repaired DNA sequence","volume":"13","author":"Mckelvey-Martin","year":"1998","journal-title":"Mutagenesis"},{"key":"10.1016\/j.jocn.2013.11.048_b0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jocn.2013.11.048_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10048-009-0206-0","article-title":"Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin","volume":"11","author":"Airoldi","year":"2010","journal-title":"Neurogenetics"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T09:54:02Z","timestamp":1538646842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0967586814001155"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.11.048","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.11.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}